Targiniq 15 mg / 7.5 mg Norge - norsk - Statens legemiddelverk

targiniq 15 mg / 7.5 mg

mundipharma as - oksykodonhydroklorid / naloksonhydrokloriddihydrat - depottablett - 15 mg / 7.5 mg

Targiniq 5 mg / 2.5 mg Norge - norsk - Statens legemiddelverk

targiniq 5 mg / 2.5 mg

mundipharma as - oksykodonhydroklorid / naloksonhydrokloriddihydrat - depottablett - 5 mg / 2.5 mg

Targiniq 10 mg / 5 mg Norge - norsk - Statens legemiddelverk

targiniq 10 mg / 5 mg

mundipharma as - oksykodonhydroklorid / naloksonhydrokloriddihydrat - depottablett - 10 mg / 5 mg

Targiniq 20 mg / 10 mg Norge - norsk - Statens legemiddelverk

targiniq 20 mg / 10 mg

mundipharma as - oksykodonhydroklorid / naloksonhydrokloriddihydrat - depottablett - 20 mg / 10 mg

Targiniq 30 mg / 15 mg Norge - norsk - Statens legemiddelverk

targiniq 30 mg / 15 mg

mundipharma as - oksykodonhydroklorid / naloksonhydrokloriddihydrat - depottablett - 30 mg / 15 mg

Targiniq 40 mg / 20 mg Norge - norsk - Statens legemiddelverk

targiniq 40 mg / 20 mg

mundipharma as - oksykodonhydroklorid / naloksonhydrokloriddihydrat - depottablett - 40 mg / 20 mg

Targin 20 mg / 10 mg Norge - norsk - Statens legemiddelverk

targin 20 mg / 10 mg

orifarm as - oksykodonhydroklorid / naloksonhydroklorid - depottablett - 20 mg / 10 mg

Targin 10 mg / 5 mg Norge - norsk - Statens legemiddelverk

targin 10 mg / 5 mg

orifarm as - oksykodonhydroklorid / naloksonhydroklorid - depottablett - 10 mg / 5 mg

Targin 40 mg / 20 mg Norge - norsk - Statens legemiddelverk

targin 40 mg / 20 mg

orifarm as - oksykodonhydroklorid / naloksonhydrokloriddihydrat - depottablett - 40 mg / 20 mg

Dimethyl fumarate Neuraxpharm Den europeiske union - norsk - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.